Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04725474 |
|---|---|
| Brief Title: | First-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer (GDFATHER) (GDFATHER) |
| First Submitted : | January 14, 2021 |
| First Submitted that Met QC Criteria : | January 25, 2021 |
| First Posted : | January 26, 2021 |
| Last Update Submitted that Met QC Criteria : | July 27, 2023 |
| Last Update Posted : | August 1, 2023 |